Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
39.48
-0.28 (-0.70%)
Apr 10, 2026, 4:00 PM EDT - Market closed
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of $6.11 billion as of April 10, 2026. Its market cap has increased by 215.31% in one year.
Market Cap
6.11B
Enterprise Value
5.93B
1-Year Change
215.31%
Ranking
Category
Stock Price
$39.48
Market Cap Chart
Since the IPO on May 28, 2021, Centessa Pharmaceuticals's market cap has increased from $1.75B to $6.11B, an increase of 249.22%. That is a compound annual growth rate of 29.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 6.11B | 67.14% |
| Dec 31, 2025 | 3.65B | 65.43% |
| Dec 31, 2024 | 2.21B | 184.18% |
| Dec 29, 2023 | 777.13M | 165.01% |
| Dec 30, 2022 | 293.25M | -71.03% |
| Dec 31, 2021 | 1.01B | -42.11% |
| May 28, 2021 | 1.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apogee Therapeutics | 6.37B |
| Protagonist Therapeutics | 6.31B |
| Terns Pharmaceuticals | 6.08B |
| Cogent Biosciences | 5.86B |
| Rhythm Pharmaceuticals | 5.76B |
| Mirum Pharmaceuticals | 5.74B |
| Scholar Rock Holding | 5.74B |
| CG Oncology | 5.72B |